Dr. Kevin James Brenzy, DO

Dr. Brenzy practices at CMG Neurology 1933 in Lynchburg, Virginia.

Dr. Brenzy's NPI, 1760821532, was assigned on June 14, 2013. Dr. Brenzy graduated from West Virginia School Of Osteopathic Medicine in 2013. Dr. Brenzy holds Virginia license 0102207735F.

Dr. Brenzy's primary practice is CMG Neurology 1933, at 2811 Linkhorne Dr, Lynchburg, VA 24503 in Lynchburg City. The practice phone is (434) 947-3928.

Dr. Brenzy's primary practice is CMG Neurology 1933 in Lynchburg, Virginia. Dr. Brenzy is also affiliated with ECU Health Medical Center. The medical group on file is Centra Medical Group. Dmand AI also links Dr. Brenzy to 2 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Brenzy practices, 5 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Brenzy's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Brenzy is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Brenzy's licenses on file in 2 states: Virginia and North Carolina.

Dmand AI lists epilepsy, essential tremor, hereditary polyneuropathy, migraine and chronic headache, muscle pain, fibromyalgia, and limb pain and vertigo among the conditions Dr. Brenzy treats.

CMS data shows 93 Medicare services from Dr. Brenzy across 4 procedure codes in 2024, for 86 Medicare patients. Medicare paid $10,378 for them. Every service was in an office.

CMS counts 86 Medicare patients who saw Dr. Brenzy in 2024. The largest group is 75 to 84, with 45 patients. 75% of them have high cholesterol, and 74% have high blood pressure. Their average risk score is 1.42, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Brenzy's median patient age at 73, with 56% women.

In 2024, Dr. Brenzy wrote 223 Medicare Part D claims for 54 patients. 96% of them were for generic drugs. CMS names the drug for 144 of them, across 5 drugs with 11 or more claims each, at $1,334 in total drug cost. In 2023, CMS named 185 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Brenzy for performance year 2024, reported through an alternative payment model (APM). Dr. Brenzy accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Brenzy as offering telehealth.

Dmand AI links 3 papers to Dr. Brenzy, published from 2017 to 2019. The most frequent topics are Ultrasonography. Dr. Brenzy has published most often in Muscle Nerve. Dr. Brenzy's most frequent co-authors are Michael S. Cartwright, MD, Vanessa Baute and Paul Francis Ehlers.

CMS Open Payments shows 206 general payments to Dr. Brenzy from 36 drug and device companies from 2017 to 2024. Food and beverage make up the largest share, 93% of the total. Allergan Inc. paid the most, $483.

Dr. Brenzy graduated from West Virginia School Of Osteopathic Medicine in 2013.

Dr. Brenzy is in network with 17 carriers, including Aetna, United Healthcare and Elevance. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.